802 related articles for article (PubMed ID: 8392915)
1. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
Comtois R; Beauregard H; Hardy J; Robert F; Somma M
Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
3. Long-term results of treatment in patients with ACTH-secreting pituitary macroadenomas.
Cannavò S; Almoto B; Dall'Asta C; Corsello S; Lovicu RM; De Menis E; Trimarchi F; Ambrosi B
Eur J Endocrinol; 2003 Sep; 149(3):195-200. PubMed ID: 12943521
[TBL] [Abstract][Full Text] [Related]
4. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M
J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
[TBL] [Abstract][Full Text] [Related]
6. Transsphenoidal resection in Cushing's disease: undetectable serum cortisol as the definition of successful treatment.
Trainer PJ; Lawrie HS; Verhelst J; Howlett TA; Lowe DG; Grossman AB; Savage MO; Afshar F; Besser GM
Clin Endocrinol (Oxf); 1993 Jan; 38(1):73-8. PubMed ID: 8435888
[TBL] [Abstract][Full Text] [Related]
7. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
8. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
[TBL] [Abstract][Full Text] [Related]
9. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
[TBL] [Abstract][Full Text] [Related]
10. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
[TBL] [Abstract][Full Text] [Related]
11. Intracavernous sinus ectopic adrenocorticotropin-secreting tumours causing therapeutic failure in transsphenoidal surgery for Cushing's disease.
Ohnishi T; Arita N; Yoshimine T; Mori S
Acta Neurochir (Wien); 2000; 142(8):855-64. PubMed ID: 11086823
[TBL] [Abstract][Full Text] [Related]
12. The pituitary ACTH, GH, LH, FSH, TSH and prolactin reserves in patients with Cushing's syndrome.
Hashimoto K
Endocrinol Jpn; 1975 Feb; 22(1):67-77. PubMed ID: 805044
[TBL] [Abstract][Full Text] [Related]
13. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
14. Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease.
Kuwayama A; Kageyama N; Nakane T; Watanabe M; Kanie N
J Clin Endocrinol Metab; 1981 Jul; 53(1):165-73. PubMed ID: 6263935
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for initial cure and relapse rate after pituitary surgery for Cushing's disease.
Pieters GF; Hermus AR; Meijer E; Smals AG; Kloppenborg PW
J Clin Endocrinol Metab; 1989 Dec; 69(6):1122-6. PubMed ID: 2555381
[TBL] [Abstract][Full Text] [Related]
16. Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results.
López J; Barceló B; Lucas T; Salame F; Alameda C; Boronat M; Salto L; Estrada J
Clin Endocrinol (Oxf); 1996 Aug; 45(2):147-56. PubMed ID: 8881446
[TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
[TBL] [Abstract][Full Text] [Related]
18. Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor.
Orth DN; DeBold CR; DeCherney GS; Jackson RV; Alexander AN; Rivier J; Rivier C; Spiess J; Vale W
J Clin Endocrinol Metab; 1982 Nov; 55(5):1017-9. PubMed ID: 6288750
[TBL] [Abstract][Full Text] [Related]
19. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
[TBL] [Abstract][Full Text] [Related]
20. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
